Cancer Insurance Market By Insurance Plan (Individual Plan, Supplement Plan, Critical Illness Plan), By Gender (Male, Female): Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

Cancer insurance is a kind of health insurance that is designed to help in the management of risk involved with cancer. The solution helps to find out the way for the cost of cancer treatment and also provides financial support to the policyholders. The solution is critical in providing ways for health-related problems like cancer and hence helps in reducing the financial impact of expenses on the individual and his family.

The primary advantage of cancer insurance is financial protection. A fair amount of fund is provided by cancer insurance policy that covers treatment expenses, recovery expenses and daily living expenses. In addition, high cost of cancer treatment that is not covered by health insurance is reduced considerably by cancer insurance policy thus making it easier for the person to pay the bills. The policy provides coverage for a variety of costs in relation to treatment, recuperation and daily living. Furthermore, the policy protects against out-of-pocket costs in relation to cancer threat and treatment that might be very expensive. Cancer insurance assist policyholders in covering costs associated with medical treatments, surgical operations, medications and therapies. Moreover, the flexibility of fund coverage provided by cancer insurance policy allows policyholder to use at different point of time for different requirements. Policyholders get the flexibility to pay for medical bills, access experimental treatments, and cover cost of transportation and other non-medical expenses such as childcare payment, mortgage payment through cancer insurance plan. In addition, cancer insurance complements regular health insurance by providing additional coverage specifically for cancer-related expenses. It acts as a supplementary policy to address the unique financial challenges associated with a cancer diagnosis.

Important players are launching various products to survive and compete in cancer insurance industry. For instance, in November 2023, GE Healthcare underwent a collaboration with BAMF Health to scale turnkey offerings that are inclusive of leading GE Healthcare technologies and services. The main objective of this strategy is to confirm that flexible approach is being implemented to improve the theranostics soltutions adoption in the U.S. The collaboration will include the combination of diagnostic and radiotherapeutic techniques to offer advanced outputs to the patient. Theranostics is a kind of technique that is available in both molecular form and target therapy form that will help in recognizing and treating cancer. Furthermore, in May 2022, Cigna Group launched provider consult service for the cancer patients. The service aims to improve the health outcomes for patients with complex cancers. The service helps in connecting patients and their community oncologist with cancer subspecialty experts at National Cancer Institute Designated Centers. The main idea behind this is that the patients benefit from connection by tapping into diagnostic innovations and evidence-based research with much ease and convenience. Therefore, such strategies adopted by key players are expected to propel the growth of cancer insurance market for the forecast period.

Growing advancement in cancer treatment and increasingly aging population are two main significant factors driving the growth of cancer insurance market. Furthermore, high costs of insurance premiums is expected to hamper the cancer insurance market growth. Moreover, rising cancer cases to provide significant opportunity for cancer insurance market growth.

The global cancer insurance market is segmented into insurance plan, gender, and region. By insurance plan, the market is divided into individual plan, supplement plan, and critical illness plan. By gender, the market is bifurcated into male and female. Region-wise, the cancer insurance market is studied across North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Competitive analysis and profiles of the major players in the cancer insurance market include AXA, Aflac, Mutual of Omaha, Aviva Plc, Prudential Plc, UNUM Group, CVS Health, China Life, Cigna Group, and United Health. These players have adopted various strategies to increase their market penetration and strengthen their position in the cancer insurance industry.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cancer insurance market analysis from 2022 to 2032 to identify the prevailing cancer insurance market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cancer insurance market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cancer insurance market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Investment Opportunities
Market share analysis of players by products/segments
New Product Development/ Product Matrix of Key Players
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Market share analysis of players at global/region/country level

Key Market Segments

By Insurance Plan

Individual Plan
Supplement Plan
Critical Illness Plan

By Gender

Male
Female

By Region

North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East and Africa
- Gcc Countries
- South Africa
- Rest of Middle East And Africa

Key Market Players:

AXA
Aflac
Mutual of Omaha
Aviva Plc
Prudential Plc
UNUM Group
CVS Health
China Life
Cigna Group
United Health

Product Code: A264275

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: CANCER INSURANCE MARKET, BY INSURANCE PLAN

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Individual Plan
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Supplement Plan
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Critical Illness Plan
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: CANCER INSURANCE MARKET, BY GENDER

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Male
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Female
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country

CHAPTER 6: CANCER INSURANCE MARKET, BY REGION

6.1. Overview
- 6.1.1. Market size and forecast By Region
6.2. North America
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by Insurance Plan
- 6.2.3. Market size and forecast, by Gender
- 6.2.4. Market size and forecast, by country
  - 6.2.4.1. U.S.
  - 6.2.4.1.1. Market size and forecast, by Insurance Plan
  - 6.2.4.1.2. Market size and forecast, by Gender
  - 6.2.4.2. Canada
  - 6.2.4.2.1. Market size and forecast, by Insurance Plan
  - 6.2.4.2.2. Market size and forecast, by Gender
6.3. Europe
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by Insurance Plan
- 6.3.3. Market size and forecast, by Gender
- 6.3.4. Market size and forecast, by country
  - 6.3.4.1. UK
  - 6.3.4.1.1. Market size and forecast, by Insurance Plan
  - 6.3.4.1.2. Market size and forecast, by Gender
  - 6.3.4.2. Germany
  - 6.3.4.2.1. Market size and forecast, by Insurance Plan
  - 6.3.4.2.2. Market size and forecast, by Gender
  - 6.3.4.3. France
  - 6.3.4.3.1. Market size and forecast, by Insurance Plan
  - 6.3.4.3.2. Market size and forecast, by Gender
  - 6.3.4.4. Italy
  - 6.3.4.4.1. Market size and forecast, by Insurance Plan
  - 6.3.4.4.2. Market size and forecast, by Gender
  - 6.3.4.5. Spain
  - 6.3.4.5.1. Market size and forecast, by Insurance Plan
  - 6.3.4.5.2. Market size and forecast, by Gender
  - 6.3.4.6. Rest of Europe
  - 6.3.4.6.1. Market size and forecast, by Insurance Plan
  - 6.3.4.6.2. Market size and forecast, by Gender
6.4. Asia-Pacific
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by Insurance Plan
- 6.4.3. Market size and forecast, by Gender
- 6.4.4. Market size and forecast, by country
  - 6.4.4.1. China
  - 6.4.4.1.1. Market size and forecast, by Insurance Plan
  - 6.4.4.1.2. Market size and forecast, by Gender
  - 6.4.4.2. Japan
  - 6.4.4.2.1. Market size and forecast, by Insurance Plan
  - 6.4.4.2.2. Market size and forecast, by Gender
  - 6.4.4.3. India
  - 6.4.4.3.1. Market size and forecast, by Insurance Plan
  - 6.4.4.3.2. Market size and forecast, by Gender
  - 6.4.4.4. Australia
  - 6.4.4.4.1. Market size and forecast, by Insurance Plan
  - 6.4.4.4.2. Market size and forecast, by Gender
  - 6.4.4.5. South Korea
  - 6.4.4.5.1. Market size and forecast, by Insurance Plan
  - 6.4.4.5.2. Market size and forecast, by Gender
  - 6.4.4.6. Rest of Asia-Pacific
  - 6.4.4.6.1. Market size and forecast, by Insurance Plan
  - 6.4.4.6.2. Market size and forecast, by Gender
6.5. Latin America
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by Insurance Plan
- 6.5.3. Market size and forecast, by Gender
- 6.5.4. Market size and forecast, by country
  - 6.5.4.1. Brazil
  - 6.5.4.1.1. Market size and forecast, by Insurance Plan
  - 6.5.4.1.2. Market size and forecast, by Gender
  - 6.5.4.2. Argentina
  - 6.5.4.2.1. Market size and forecast, by Insurance Plan
  - 6.5.4.2.2. Market size and forecast, by Gender
  - 6.5.4.3. Rest of Latin America
  - 6.5.4.3.1. Market size and forecast, by Insurance Plan
  - 6.5.4.3.2. Market size and forecast, by Gender
6.6. Middle East and Africa
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by Insurance Plan
- 6.6.3. Market size and forecast, by Gender
- 6.6.4. Market size and forecast, by country
  - 6.6.4.1. Gcc Countries
  - 6.6.4.1.1. Market size and forecast, by Insurance Plan
  - 6.6.4.1.2. Market size and forecast, by Gender
  - 6.6.4.2. South Africa
  - 6.6.4.2.1. Market size and forecast, by Insurance Plan
  - 6.6.4.2.2. Market size and forecast, by Gender
  - 6.6.4.3. Rest of Middle East And Africa
  - 6.6.4.3.1. Market size and forecast, by Insurance Plan
  - 6.6.4.3.2. Market size and forecast, by Gender

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

8.1. AXA
- 8.1.1. Company overview
- 8.1.2. Key executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.1.7. Key strategic moves and developments
8.2. Aflac
- 8.2.1. Company overview
- 8.2.2. Key executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
8.3. Mutual of Omaha
- 8.3.1. Company overview
- 8.3.2. Key executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
- 8.3.7. Key strategic moves and developments
8.4. Aviva Plc
- 8.4.1. Company overview
- 8.4.2. Key executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.4.7. Key strategic moves and developments
8.5. Prudential Plc
- 8.5.1. Company overview
- 8.5.2. Key executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
- 8.5.7. Key strategic moves and developments
8.6. UNUM Group
- 8.6.1. Company overview
- 8.6.2. Key executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.6.7. Key strategic moves and developments
8.7. CVS Health
- 8.7.1. Company overview
- 8.7.2. Key executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Business performance
- 8.7.7. Key strategic moves and developments
8.8. China Life
- 8.8.1. Company overview
- 8.8.2. Key executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
- 8.8.7. Key strategic moves and developments
8.9. Cigna Group
- 8.9.1. Company overview
- 8.9.2. Key executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
- 8.9.7. Key strategic moves and developments
8.10. United Health
- 8.10.1. Company overview
- 8.10.2. Key executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Business performance
- 8.10.7. Key strategic moves and developments